Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The primary research interest of Michael T. Barrett, Ph.D., is to comprehensively study the clonal evolution of neoplasia and cancer in patients who are at risk of or have already progressed to malignant disease.
The fundamental hypothesis of Dr. Barrett's research is that clonally selected events, such as gene mutations and amplifications that are essential for the progression to cancer, represent highly favorable markers and targets that can be exploited for improved patient care.
Dr. Barrett's overall interest in the role of genomic instability in the evolution of cancer is directed toward fulfilling the need for high-definition tools to study the complex nature of cancer genomes. He works to apply genomic tools and technologies to develop and advance more-effective therapeutic strategies for patients with cancer.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.